Latest News of CTXR
When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Turn A Profit?
By Yahoo! Finance |
3 months ago
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company aiming for profitability soon. Analysts project it to break even in 2025 with a 63% annual growth rate. The absence of debt reduc...
Citius Pharmaceuticals, Inc. (CTXR) Stock Price, News, Quote & History
By Yahoo! Finance |
4 months ago
Citius Pharmaceuticals is a biopharmaceutical company focusing on critical care products. They have two late-stage product candidates, Mino-Lok and LYMPHIR, with ongoing clinical trials. The company i...